LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Cerevel Therapeutics and Millions of Other Companies

Sign up for full access to Cerevel Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Recent Acquisition Cerevel Therapeutics being acquired by AbbVie for $8.7 billion presents an opportunity to leverage the expanded resources and market presence for increased sales collaboration and cross-selling initiatives within the pharmaceutical industry.

Neuroscience Focus With AbbVie's strategic move to strengthen its foundation in neuroscience through the acquisition of Cerevel Therapeutics, there is potential for targeting customers interested in neurology and psychiatric treatments with innovative solutions and therapies.

Industry Similarity Being in the pharmaceutical manufacturing industry alongside key players like AbbVie, Amgen, and Johnson & Johnson, Cerevel Therapeutics can explore partnership opportunities, knowledge sharing, and market expansion leveraging industry solidarity.

Financial Stability The significant funding of $450 million and revenue potential of Cerevel Therapeutics positions the company well for strategic sales growth, allowing for investments in sales and marketing efforts to reach a wider customer base and generate higher sales revenue.

Global Presence With a global presence and offices in North Chicago, Cerevel Therapeutics has the opportunity to tap into international markets, forge alliances with multinational pharmaceutical companies, and establish distribution channels for expanding sales reach globally.

Similar companies to Cerevel Therapeutics

✕

Access Insights for Cerevel Therapeutics and Millions of Other Companies

Sign up for full access to Cerevel Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Cerevel Therapeutics Tech Stack

Cerevel Therapeutics uses 8 technology products and services including Oracle ERP, React, PWA, and more. Explore Cerevel Therapeutics's tech stack below.

  • Oracle ERP
    Enterprise
  • React
    Javascript Frameworks
  • PWA
    Miscellaneous
  • Office 365
    Office Suites
  • Microsoft Azure
    Platform As A Service
  • Smartsheet
    Project Management
  • FedEx
    Transportation And Fleet Management
  • Django
    Web Frameworks

Media & News

Cerevel Therapeutics's Email Address Formats

Cerevel Therapeutics uses at least 1 format(s):
Cerevel Therapeutics Email FormatsExamplePercentage
First.Last@cerevel.comJohn.Doe@cerevel.com
98%
First.L@cerevel.comJohn.D@cerevel.com
2%

Frequently Asked Questions

Where is Cerevel Therapeutics's headquarters located?

Minus sign iconPlus sign iconCerevel Therapeutics's main headquarters is located at 1 N Waukegan Rd North Chicago, Illinois 60064 US. The company has employees across 2 continents, including North AmericaEurope.

What is Cerevel Therapeutics's stock symbol?

Minus sign iconPlus sign iconCerevel Therapeutics is a publicly traded company; the company's stock symbol is CERE.

What is Cerevel Therapeutics's official website and social media links?

Minus sign iconPlus sign iconCerevel Therapeutics's official website is cerevel.com and has social profiles on LinkedIn.

How much revenue does Cerevel Therapeutics generate?

Minus sign iconPlus sign icon As of November 2024, Cerevel Therapeutics's annual revenue reached $501B.

What is Cerevel Therapeutics's NAICS code?

Minus sign iconPlus sign iconCerevel Therapeutics's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Cerevel Therapeutics have currently?

Minus sign iconPlus sign iconAs of November 2024, Cerevel Therapeutics has approximately 10K employees across 2 continents, including North AmericaEurope. Key team members include Chief Executive Officer: S. Y.Chief Executive Officer: T. C.Chief Legal Officer & Corporate Secretary: S. A.. Explore Cerevel Therapeutics's employee directory with LeadIQ.

What industry does Cerevel Therapeutics belong to?

Minus sign iconPlus sign iconCerevel Therapeutics operates in the Pharmaceutical Manufacturing industry.

What technology does Cerevel Therapeutics use?

Minus sign iconPlus sign iconCerevel Therapeutics's tech stack includes Oracle ERPReactPWAOffice 365Microsoft AzureSmartsheetFedExDjango.

What is Cerevel Therapeutics's email format?

Minus sign iconPlus sign iconCerevel Therapeutics's email format typically follows the pattern of . Find more Cerevel Therapeutics email formats with LeadIQ.

How much funding has Cerevel Therapeutics raised to date?

Minus sign iconPlus sign icon As of November 2024, Cerevel Therapeutics has raised $450M in funding. The last funding round occurred on Oct 11, 2023 for $450M.
Cerevel Therapeutics

Cerevel Therapeutics

Pharmaceutical ManufacturingIllinois, United States10001+ Employees

Cerevel is now part of AbbVie. 

AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need.  

For more information about AbbVie, please visit us at www.abbvie.com. Follow @AbbVie on LinkedIn for future updates.

✕

Access Insights for Cerevel Therapeutics and Millions of Other Companies

Sign up for full access to Cerevel Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
1 N Waukegan Rd North Chicago, Illinois 60064 US
Website
cerevel.com
Stock Symbol
CERE
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
10001+

Section iconMedia & News

Section iconFunding & Financials

  • $450M

    Cerevel Therapeutics has raised a total of $450M of funding over 6 rounds. Their latest funding round was raised on Oct 11, 2023 in the amount of $450M.

  • $1B

    Cerevel Therapeutics's revenue is in the range of $1B

Section iconFunding & Financials

  • $450M

    Cerevel Therapeutics has raised a total of $450M of funding over 6 rounds. Their latest funding round was raised on Oct 11, 2023 in the amount of $450M.

  • $1B

    Cerevel Therapeutics's revenue is in the range of $1B

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Cerevel Therapeutics and Millions of Other Companies

Sign up for full access to Cerevel Therapeutics information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.